Gene · 6336
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement. | J Arrhythm | 2026 | 41738055 | PubTator, text mining | PubMed |
| Progress in the study of ion channel function, mechanisms, and mathematical modeling in Parkinson's disease. | iScience | 2026 | 41732483 | PubTator, text mining | PubMed |
| Structure-function analysis of the lithium-ion selectivity of the voltage-gated sodium channel. | J Gen Physiol | 2026 | 41711638 | PubTator, text mining | PubMed |
| Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy. | Diabetes Metab Syndr Obes | 2026 | 41710719 | PubTator, text mining | PubMed |
| Selective Nav1.8 inhibition by suzetrigine, a novel nonopioid analgesic for acute pain management: A systematic review and metanalysis. | Saudi J Anaesth | 2026 | 41710612 | PubTator, text mining | PubMed |
| A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. | ACS Chem Neurosci | 2026 | 41704197 | PubTator, text mining | PubMed |
| Suzetrigine, a novel nonopioid analgesic for acute pain. | Curr Opin Anaesthesiol | 2026 | 41704079 | PubTator, text mining | PubMed |
| The Clinical Application of Suzetrigine. | J Pain Palliat Care Pharmacother | 2026 | 41689837 | PubTator, text mining | PubMed |
| Targeting Nav Channels for Pain Relief: Structural Insights and Therapeutic Opportunities. | Int J Mol Sci | 2026 | 41683608 | PubTator, text mining | PubMed |
| Suzetrigine as a Complementary Analgesic in Dentistry: Evidence, Limitations, and Future Directions for a Novel NaV1.8 Inhibitor. | Int Dent J | 2026 | 41653837 | PubTator, text mining | PubMed |
| Human Dorsal Root Ganglia Neuronal Cell Line to Study Nociceptive Signaling: A New Pipeline for Pain Therapy. | FASEB J | 2026 | 41631387 | PubTator, text mining | PubMed |
| Exceptionally selective voltage-sensor trapping of NaV1.5 channels by Mg-protoporphyrin impairs cancer cell migration. | Sci Rep | 2026 | 41611918 | PubTator, text mining | PubMed |
| Association between temporomandibular disorders and somatization: a narrative review. | J Oral Facial Pain Headache | 2026 | 41607321 | PubTator, text mining | PubMed |
| Suzetrigine, a NaV1.8 Inhibitor as a Novel Approach for Pain Therapy-A Medicinal and Chemical Drug Profile. | Molecules | 2026 | 41599406 | PubTator, text mining | PubMed |
| The psychoactive cannabinoid THC inhibits peripheral nociceptors by targeting NaV1.7 and NaV1.8 nociceptive sodium channels. | Neuropsychopharmacology | 2026 | 41565997 | PubTator, text mining | PubMed |
| Whole-exome sequencing in obstructive coronary artery disease identifies rare and novel variants in cardiac arrhythmia and pulmonary arterial hypertension-associated genes. | Biomol Biomed | 2026 | 41564389 | PubTator, text mining | PubMed |
| Genomic Structural Equation Modeling Combined With Post-GWAS Analysis Identifies Two Risk Gene Loci and Functionally Sensitive Genes Associated With Cardiac Conduction Block. | Genet Res (Camb) | 2026 | 41541644 | PubTator, text mining | PubMed |
| Suzetrigine, a selective NaV1.8 inhibitor in acute and chronic pain: mechanistic insights, clinical outcomes, and future perspectives. | Curr Opin Anaesthesiol | 2026 | 41481839 | PubTator, text mining | PubMed |
| Piezo1-mediated neuroexcitation via collaboration with KCa1.1 and Nav1.9 currents in myelinated Ah-type of trigeminal ganglion neurons in rats: Mechanistic insights with sex-specific effects. | Mol Pain | 2026 | 41384612 | PubTator, text mining | PubMed |
| A nociceptor excitability test for identifying alterations of the Nav1.7 channels in humans. | Pain | 2026 | 41263818 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6336/papers?page=5